002620.KS
Jeil Pharma Holdings Inc
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,780.00
−1.74%Leverage
- Debt / equity
- 0.59x
- Net debt / equity
- 0.39x
- Debt / assets
- 0.21x
- Debt / EBITDA
- -4.71x
- Net debt / EBITDA
- -3.11x
Liquidity & coverage
- Current ratio
- 1.20x
- Quick ratio
- 0.85x
- Cash ratio
- 0.27x
- Interest coverage
- -0.56x
- EBITDA / interest
- -5.30x
- Working capital
- KRW 66.1B
Cash & dividend
- FCF / debt
- -0.01x
- Cash flow / debt
- 0.06x
- Dividend per share
- KRW 70
- Dividend yield
- 1.0%
- Dividend growth 1y
- +40.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026